• Home  /
  • Research & Analysis   /
  • Two Volume Gainers: Constellation Brands Inc. (NYSE:STZ), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

Two Volume Gainers: Constellation Brands Inc. (NYSE:STZ), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

Constellation Brands Inc. (NYSE:STZ)

The shares of Constellation Brands Inc. (NYSE:STZ) started off the last trading session with the price of $227.52 while closing the day with the price of $228.54. The shares of Constellation Brands Inc. (NYSE:STZ) Rise 0.73% with the Gain of 1.02 points.

The shares of Constellation Brands Inc. (NYSE:STZ) traded with the day volume of 1.22 Million shares whereas its average trading volume is 1.95 Million.

While analyzing the past performance of the stock we can see that the shares of Constellation Brands Inc. (NYSE:STZ) Loss -0.78% in the last week while rising 6.79% in the last month. Past quarter performance shows the green light with 4.56%. The semi-annual and annual performance shows 11.82% and 41.04% respectively.

Some critical values of the shares of Constellation Brands Inc. (NYSE:STZ) to be discussed here are: the beta which shows the value at 0.13 while Average True Range of Constellation Brands Inc. (NYSE:STZ) demonstrate the value at 4.07. The weekly and monthly volatility of the shares of Constellation Brands Inc. (NYSE:STZ) are indicated at 1.31% and 1.82%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 63.65.

While studying the financial position of the shares of Constellation Brands Inc. (NYSE:STZ), we can see that the Market capitalization of the company is at 44.2 Billion. The shares outstanding for the company is 193.38 Million and the shares float stands at 170.18 Million. The income of the company stand at 1.85 Billion while the sales stand at 7.45 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 8.23, Price to Earnings or P/E is at 27.77, Price to Sales P/S show the value of 5.93, the Return on Asset ROA stood at 0.096 and the Return on Equity ROE depicted at 0.244 while Return on Investment ROI is at 0.114.


Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) started its previous trading session at $2.94 and closed at $3.07 showing a Rise of 4.42 Percent.

The Company traded with an average Volume of 1.46 Million whereas, its Day Volume stood at 1.22 Million.

Looking at the performance of the stock, Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Gain 5.86% in the last week in its shares price and 42.79% in the last month. Quarterly performance shows a red of -47.88 Percent while Semi-Annual and Annual performances shows a -55.38 and -60.99 percent respectively.

Beta for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) stands at 2.75 while the ATR (average true range) is at 0.35. The Stock’s Weekly and Monthly Volatility is 9.90% and 9.97% respectively showing a RSI value of 43.03.

While studying the financial position of the shares of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), we can see that the Market capitalization of the company is at 158.11 Million. The shares outstanding for the company is 51.5 Million and the shares float stands at 51.34 Million.

The Company generated an income of -114800000 and the sales of 9.7 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.72 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 16.3 respectively.

The Return on Assets stands at -0.786, ROE shows a value of -0.908 and ROI for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) is -0.887 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment